ArticleiScience2025
Dual-action thioarylamide-based small molecules to target drug-resistant bacteria and chronic inflammation.
Maria De Fenza et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it